Year in review: Who were the main DCT players in 2022?
Clinical Trials Arena reviews the companies and countries that mentioned decentralization most often in their clinical trial protocols....
Clinical Trials Arena reviews the companies and countries that mentioned decentralization most often in their clinical trial protocols....
New chancellor Jennifer L. Mnookin crafts a "collective vision" for the university's future....
Research programs and studies that are built on a DEI foundation will inevitably have a positive influence on the trajectory of goals that include increasing diversity in clinical trials and cultivating inclusive environments for the biomedical research workforce....
The University of Wisconsin–Madison ranks eighth in national research rankings for public and private universities and increased research expenditures across all fields....
A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....
As the tolerance bar for excluding clinical trials participants on the grounds of race and sex lowers significantly, exclusion based on cognitive disability still goes on....
Children who participate in clinical trials can help provide researchers with information adults cannot....
UW–Madison was chosen as a Center of Excellence due to its elite level of comprehensive, multi-disciplinary care and access to leading clinical research and new therapies for patients with polycystic kidney disease (PKD)....
Grant from US Centers for Disease Control and Prevention to advance public health workforce development at state and local levels over the next five years....
BioForward's Lisa Johnson discusses the strength of Wisconsin's biohealth sector....